These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27879540)

  • 21. Don't neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia.
    Ucar İ; Koyuncu MB; Solmaz AA; Ugurludogan AC; Mercan S; Kucuk M; Unal T; Mazman S; Atilla E
    Transfus Clin Biol; 2023 Feb; 30(1):11-15. PubMed ID: 36028153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein.
    Victoria EJ; Pierce SW; Branks MJ; Masouredis SP
    J Lab Clin Med; 1990 Jan; 115(1):74-88. PubMed ID: 1688911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune hemolysis-serological and clinical aspects.
    Pruss A; Salama A; Ahrens N; Hansen A; Kiesewetter H; Koscielny J; Dörner T
    Clin Exp Med; 2003 Sep; 3(2):55-64. PubMed ID: 14598182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
    Alioglu B; Avci Z; Ozyurek E; Ozbek N
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
    Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
    Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.
    Kimura M; Harazaki M; Fukuoka T; Asakura I; Sakai H; Kamimaki T; Ohkawara I; Akiyama N; Tsurui S; Iwashima S; Shimomura M; Morishita H; Meguro T; Seto S
    Pediatr Int; 2017 Apr; 59(4):397-403. PubMed ID: 27743415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Rh D activity of commercial intravenous immunoglobulin preparations.
    Turner CE; Thorpe SJ; Brasher MD; Thorpe R
    Vox Sang; 1999; 76(1):55-8. PubMed ID: 9933855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specifications for anti-A and anti-B in intravenous immunoglobulin: history and rationale.
    Thorpe SJ
    Transfusion; 2015 Jul; 55 Suppl 2():S80-5. PubMed ID: 26174902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autoimmune hemolytic anemia with temporary weakening of Gerbich antigens].
    Göttsche B; Salama A; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():406-8. PubMed ID: 1703886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
    Hwang JY; Lee KY; Rhim JW; Youn YS; Oh JH; Han JW; Lee JS; Burgner D
    Arch Dis Child; 2011 Nov; 96(11):1088-90. PubMed ID: 20551193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful management of severe chronic autoimmune hemolytic anemia with low dose cyclosporine and prednisone in an infant.
    Yarali N; Fişgin T; Kara A; Duru F
    Turk J Pediatr; 2003; 45(4):335-7. PubMed ID: 14768800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemolytic anemia associated with intravenous immunoglobulin.
    Wilson JR; Bhoopalam H; Fisher M
    Muscle Nerve; 1997 Sep; 20(9):1142-5. PubMed ID: 9270670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune hemolytic anemia after Kawasaki disease in a child.
    Panzarino V; Estrada J; Benson K; Postoway N; Garratty G
    Int J Hematol; 1993 Jun; 57(3):259-63. PubMed ID: 8364188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune hemolytic anemia associated with an IgA autoanti-Gerbich.
    Göttsche B; Salama A; Mueller-Eckhardt C
    Vox Sang; 1990; 58(3):211-4. PubMed ID: 2339532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to intravenous immunoglobulin G in an infant with immunoglobulin A-associated autoimmune haemolytic anaemia.
    Hoppe B; Gaedicke G; Kiesewetter H; Salama AR
    Vox Sang; 2004 Feb; 86(2):151-3. PubMed ID: 15023187
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice.
    Tanyer G; Siklar Z; Dallar Y; Yildirmak Y; Tiraş U
    J Trop Pediatr; 2001 Feb; 47(1):50-3. PubMed ID: 11245352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in Hemoglobin Concentrations Post-immunoglobulin Therapy in Patients with Kawasaki Disease: A Population-Based Study Using a Claims Database in Japan.
    Takeuchi M; Ito S; Nakamura M; Kawakami K
    Paediatr Drugs; 2018 Dec; 20(6):585-591. PubMed ID: 30345488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kawasaki disease with autoimmune hemolytic anemia.
    Thakkar D; Radhakrishnan N; Pruthi PK; Sachdeva A
    Indian Pediatr; 2015 Mar; 52(3):245-6. PubMed ID: 25849007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.